|Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women||
||Other / Industry||
||16||Female||45 Years to 60 Years (Adult)||NCT00611533||0403026533||May 2004||April 2008||April 2008||February 11, 2008||April 17, 2017||March 3, 2017||
|2||NCT00745056||Active, not recruiting||Examining the Relationship Between Hormone Therapy (HT) and Cognitive Function (The WHIMS-ECHO Study)||
||2922||Female||65 Years and older (Adult, Senior)||NCT00745056||1436||WHIMS-ECHO||August 2008||November 2021||November 2021||September 1, 2008||November 6, 2017||
|3||NCT00000611||Completed||Women's Health Initiative (WHI)||
||Female||50 Years to 79 Years (Adult, Senior)||NCT00000611||114||March 2005||October 28, 1999||April 15, 2016|
† Study has passed its completion date and status has not been verified in more than two years.